Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.09 Million ILS | 211.76% |
| 2022 | -19.76 Million ILS | -72.55% |
| 2021 | -11.45 Million ILS | -168.89% |
| 2020 | 16.62 Million ILS | 208.16% |
| 2019 | -15.37 Million ILS | -315.09% |
| 2018 | -3.7 Million ILS | -7162.75% |
| 2017 | -51 Thousand ILS | 98.43% |
| 2016 | -3.24 Million ILS | 0.29% |
| 2015 | -3.24 Million ILS | 50.82% |
| 2014 | -6.6 Million ILS | -40.43% |
| 2013 | -4.7 Million ILS | -12.03% |
| 2012 | -4.2 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 6.2 Million ILS | 10.29% |
| 2024 Q2 | 6.2 Million ILS | 0.0% |
| 2023 Q2 | 5.41 Million ILS | 0.0% |
| 2023 Q3 | 5.63 Million ILA | 3.93% |
| 2023 Q4 | 5.63 Million ILS | 0.0% |
| 2023 FY | 22.09 Million ILS | 211.76% |
| 2023 Q1 | 5.41 Million ILS | 292.78% |
| 2022 FY | -19.76 Million ILS | -72.55% |
| 2022 Q1 | -7.07 Million ILS | 47.79% |
| 2022 Q2 | -7.07 Million ILS | 0.0% |
| 2022 Q3 | -2.81 Million ILS | 60.28% |
| 2022 Q4 | -2.81 Million ILS | 0.0% |
| 2021 FY | -11.45 Million ILS | -168.89% |
| 2021 Q4 | -13.54 Million ILS | -2813.76% |
| 2021 Q3 | -465 Thousand ILS | -142.9% |
| 2021 Q2 | 1.08 Million ILS | -49.23% |
| 2021 Q1 | 2.13 Million ILS | 192.83% |
| 2020 Q3 | 7.4 Million ILS | -18.81% |
| 2020 Q2 | 9.12 Million ILS | 279.77% |
| 2020 FY | 16.62 Million ILS | 208.16% |
| 2020 Q1 | 2.4 Million ILS | 159.86% |
| 2020 Q4 | -2.3 Million ILS | -131.06% |
| 2019 Q1 | -3.67 Million ILS | -158.31% |
| 2019 Q4 | -4.01 Million ILS | 0.0% |
| 2019 FY | -15.37 Million ILS | -315.09% |
| 2019 Q2 | -3.67 Million ILS | 0.0% |
| 2019 Q3 | -4.01 Million ILS | -9.21% |
| 2018 Q4 | -1.42 Million ILS | 0.0% |
| 2018 Q1 | -429.5 Thousand ILS | -2763.33% |
| 2018 Q2 | -429.5 Thousand ILS | 0.0% |
| 2018 FY | -3.7 Million ILS | -7162.75% |
| 2018 Q3 | -1.42 Million ILS | -231.2% |
| 2017 Q2 | -10.5 Thousand ILS | 0.0% |
| 2017 FY | -51 Thousand ILS | 98.43% |
| 2017 Q4 | -15 Thousand ILS | 0.0% |
| 2017 Q3 | -15 Thousand ILS | -42.86% |
| 2017 Q1 | -10.5 Thousand ILS | 99.1% |
| 2016 Q4 | -1.17 Million ILS | -92.86% |
| 2016 Q2 | -833.32 Thousand ILS | 22.84% |
| 2016 Q3 | -607.32 Thousand ILS | 27.12% |
| 2016 Q1 | -1.07 Million ILS | -515.91% |
| 2016 FY | -3.24 Million ILS | 0.29% |
| 2015 FY | -3.24 Million ILS | 50.82% |
| 2015 Q2 | 313.22 Thousand ILS | 135.79% |
| 2015 Q1 | -875.18 Thousand ILS | 15.87% |
| 2015 Q3 | -317.6 Thousand ILS | -201.4% |
| 2015 Q4 | -175.34 Thousand ILS | 44.79% |
| 2014 Q3 | -1.86 Million ILS | 8.82% |
| 2014 Q1 | -1.14 Million ILS | 29.83% |
| 2014 FY | -6.6 Million ILS | -40.43% |
| 2014 Q4 | -1.04 Million ILS | 44.18% |
| 2014 Q2 | -2.04 Million ILS | -79.1% |
| 2013 Q2 | -948.98 Thousand ILS | 1.79% |
| 2013 FY | -4.7 Million ILS | -12.03% |
| 2013 Q3 | -1.27 Million ILS | -34.52% |
| 2013 Q4 | -1.62 Million ILS | -27.39% |
| 2013 Q1 | -966.26 Thousand ILS | -5.2% |
| 2012 Q4 | -918.49 Thousand ILS | 5.13% |
| 2012 FY | -4.2 Million ILS | 0.0% |
| 2012 Q3 | -968.16 Thousand ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cannabotech LTD | -16.62 Million ILA | 232.896% |